FIELD: medicine; hematology; transfusiology.
SUBSTANCE: after the mobilization procedure and before the HSC collection, a patient’s blood sample is taken. Concentration of CD34+ cells in a blood sample is determined. Collecting a dose of HSC from 5 x 106/kg to 10 x 106/kg and a dose of HSC 10 x 106/kg and more is predicted depending on a certain concentration of CD34+ cells in a blood sample.
EFFECT: method provides effective determination of the probability of collecting the target dose of HSC depending on the number of circulating CD34+ cells.
1 cl, 1 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING EFFECTIVE MOBILISATION OF HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA | 2020 |
|
RU2757964C1 |
| BIOMEDICAL CELL PRODUCT, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2741769C2 |
| AUTOLOGIC HEMOPOIETIC STEM CELLS PREPARATION AND METHOD FOR PRODUCING, CRYOGENIC PRESERVING AND APPLYING IT IN TREATING TRAUMATIC NERVOUS SYSTEM DISEASE CASES | 2005 |
|
RU2283119C1 |
| METHOD FOR PREDICTING DISEASE-FREE SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION | 2015 |
|
RU2580648C1 |
| METHOD OF TREATING NEWLY DIAGNOSED HIGH-RISK STAGE 4 NEUROBLASTOMA IN CHILDREN OVER 18 MONTHS BASED ON INDUCTION CHEMOIMMUNOTHERAPY | 2024 |
|
RU2839951C1 |
| BIOMEDICAL CELL PREPARATION | 2017 |
|
RU2647429C1 |
| BIOMEDICAL CELL PRODUCT FOR TREATING NERVOUS DISEASES AND MENTAL DISORDERS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2018 |
|
RU2720002C1 |
| ANTITUMOR TARGET CELL PRODUCT, METHOD FOR ITS PRODUCTION AND ITS APPLICATION | 2018 |
|
RU2757812C2 |
| PERSONALIZED METHOD OF BONE MARROW RESTITUTION FOR CONTROLLING PROGRESSION AND RECURRENCES OF VARIOUS CIVILIZATION DISEASES, PREVENTING AGING AND SUDDEN DEATH | 2023 |
|
RU2817892C1 |
| COMPOSITIONS AND METHODS OF STEM CELL TRANSPLANTATION | 2019 |
|
RU2809803C2 |
